Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Teaching Points and Conclusions in DTC

April 1st 2016

Emerging Therapies in Differentiated Thyroid Cancer

April 1st 2016

Sequencing in DTC: Lenvatinib and Sorafenib

April 1st 2016

TKI Dose Adjustment in Advanced DTC

April 1st 2016

Safety and Efficacy of Lenvatinib in Advanced DTC

April 1st 2016

Efficacy and Toxicity of Sorafenib in Advanced DTC

April 1st 2016

TKI Therapy for Advanced Thyroid Cancer

April 1st 2016

Systemic Therapy for RAI-Refractory DTC

April 1st 2016

RAI-Refractory Defined

April 1st 2016

Multidisciplinary Care: High-Risk DTC

April 1st 2016

Multidisciplinary Care of Low/Intermediate Risk DTC

April 1st 2016

Moving Toward Personalized Medicine in Advanced DTC

April 1st 2016

Molecular Testing in Thyroid Cancer

April 1st 2016

Initial Workup for Differentiated Thyroid Cancer

April 1st 2016

Expert Projects 2016 FDA Approvals of Nivolumab and Pembrolizumab in Head and Neck Cancer

March 28th 2016

Tanguy Seiwert, MD, discusses the impact of the CheckMate-141 trial in head and neck cancer, the importance of establishing an effective biomarker, and the significance a manageable toxicity profile may have on patients with poor performance status.

Mutational Analysis Advances Precision Medicine in Head and Neck Cancer

March 28th 2016

Ezra Cohen, MD, discusses results of a biomarker analysis and the next steps in understanding biomarkers for afatinib in patients with head and neck cancer.

ACS Publishes New Guideline for Head and Neck Cancer Survivorship Care

March 28th 2016

An expert panel has developed clinical practice guidelines for the management of head and neck cancer survivors.

Dr. Sher on ASTRO's Head and Neck Cancer Guideline Update

March 24th 2016

David Sher, MD, radiation oncologist, UT Southwestern Medical Center, provides an update on and the basis for ASTRO's Multidisciplinary Head and Neck Cancer Guideline.

Emerging Therapies in HNSCC

March 21st 2016

The Use of Immunotherapy in HNSCC

March 21st 2016